← All trials
NCT02741856
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2016
- Primary completion
- Apr 1, 2021
- Completion date
- Apr 1, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 584
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Cardiff UniversityLead sponsor
- Velindre NHS TrustSponsor investigator
- Cancer Research UKCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.